Oral GLP‑1 shows promise but nausea may still bite

Posted by amber464 in Weight Loss & Metabolic - 1 points, 0 comments.

https://pharmaphorum.com/news/kaileras-big-obesity-reveal-puts-pressure-shares

The BioSpace piece covers Hengrui and Kailera’s oral GLP‑1 (KAI‑7535) clearing a late‑stage regulatory hurdle in China, with phase‑3 data showing solid weight loss but a high incidence of nausea and vomiting.

I think the article is a bit too upbeat. The efficacy numbers look decent, around 10‑12% body weight loss, but the tolerability signal is a red flag. In my own titration runs with oral GLP‑1 analogs, the nausea curve often spikes around 0.5‑1 mg and can linger for weeks, which messes with food intake tracking and HRV readings. The piece glosses over how those side effects might force dose interruptions, something that can blunt the overall loss curve. Also, the data is China‑only; metabolic differences and diet patterns could shift the safety profile elsewhere.

Has anyone tried a slower ramp or added anti‑nausea protocols (like ginger or ondansetron) with oral GLP‑1s and seen a smoother tolerance curve? What’s your tweak?

Community discussion - research and educational context only. Not medical advice.